These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12717271)

  • 21. Predicting post-endoscopic retrograde cholangiopancreatography pancreatitis using the 4-h serum lipase level.
    Papachristos A; Howard T; Thomson BN; Thomas PR
    ANZ J Surg; 2018 Jan; 88(1-2):82-86. PubMed ID: 27457275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does gabexate mesilate affect serum concentrations of acute phase proteins after endoscopic retrograde cholangiopancreatography examination?
    Pezzilli R; Gabbrielli A; Labate AM; D'Alessio P; Barakat B; Costamagna G; Dibenedetti F; Massa M; Merlini G; d'Eril GM
    Hepatogastroenterology; 2003; 50(51):851-5. PubMed ID: 12828103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid urinary trypsinogen-2 test strip in the diagnosis of pancreatitis after endoscopic retrograde cholangiopancreatography.
    Tseng CW; Chen CC; Lin SZ; Chang FY; Lin HC; Lee SD
    Pancreas; 2011 Nov; 40(8):1211-4. PubMed ID: 21946810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of selected parameters of the inflammatory response to endoscopic retrograde cholangiopancreatography.
    Woźniak B; Wiśniewska-Jarosińska M; Drzewoski J
    Pancreas; 2001 Nov; 23(4):349-55. PubMed ID: 11668202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholecystokinin in the early course of acute post-ERCP pancreatitis.
    Räty S; Sand J; Laine S; Harmoinen A; Nordback I
    J Am Coll Surg; 1999 Dec; 189(6):560-5. PubMed ID: 10589592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Pande H; Thuluvath P
    Drugs; 2003; 63(17):1799-812. PubMed ID: 12921486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The value of serum amylase and elastase measurements in the prediction of post-ERCP acute pancreatitis.
    Kapetanos D; Kokozidis G; Kinigopoulou P; Xiarchos P; Antonopoulos Z; Progia E; Kitis G
    Hepatogastroenterology; 2007 Mar; 54(74):556-60. PubMed ID: 17523321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral udenafil and aceclofenac for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a randomized multicenter study.
    Lee TY; Choi JS; Oh HC; Song TJ; Do JH; Cheon YK
    Korean J Intern Med; 2015 Sep; 30(5):602-9. PubMed ID: 26354054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of recombinant human interleukin-10 in prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis in subjects with increased risk.
    Sherman S; Cheng CL; Costamagna G; Binmoeller KF; Puespoek A; Aithal GP; Kozarek RA; Chen YK; Van Steenbergen W; Tenner S; Freeman M; Monroe P; Geffner M; Deviere J;
    Pancreas; 2009 Apr; 38(3):267-74. PubMed ID: 19214137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis.
    Milewski J; Rydzewska G; Degowska M; Kierzkiewicz M; Rydzewski A
    World J Gastroenterol; 2006 Jun; 12(23):3751-5. PubMed ID: 16773694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary trypsinogen-2 test strip in detecting ERCP-induced pancreatitis.
    Kemppainen E; Hedström J; Puolakkainen P; Halttunen J; Sainio V; Haapiainen R; Stenman UH
    Endoscopy; 1997 May; 29(4):247-51. PubMed ID: 9255526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bactericidal/permeability-increasing protein and group I and II phospholipase A2 during the induction phase of human acute pancreatitis.
    Kemppainen E; Hietaranta A; Puolakkainen P; Sainio V; Halttunen J; Haapiainen R; Kivilaakso E; Nevalainen T
    Pancreas; 1999 Jan; 18(1):21-7. PubMed ID: 9888656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial.
    Poon RT; Yeung C; Liu CL; Lam CM; Yuen WK; Lo CM; Tang A; Fan ST
    Gut; 2003 Dec; 52(12):1768-73. PubMed ID: 14633959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemerin: a new biomarker to predict postendoscopic retrograde cholangiopancreatography pancreatitis.
    Koksal AR; Boga S; Alkim H; Sen I; Neijmann ST; Alkim C
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):714-21. PubMed ID: 26854798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No Benefit of Oral Diclofenac on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Ishiwatari H; Urata T; Yasuda I; Matsusaki S; Hisai H; Kawakami H; Ono M; Iwashita T; Doi S; Kawakubo K; Hayashi T; Sonoda T; Sakamoto N; Kato J
    Dig Dis Sci; 2016 Nov; 61(11):3292-3301. PubMed ID: 27447477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic Value of Serum Amylase Levels Indicating Computed Tomography-Defined Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Prospective Multicenter Observational Study.
    Inatomi O; Bamba S; Nakai Y; Kusumoto K; Kawakami T; Suzuki T; Suzuki A; Endoh B; Ota S; Inoue A; Itokawa Y; Chikugo K; Andoh A; Mizumoto Y; Tanaka K
    Pancreas; 2020 Aug; 49(7):955-959. PubMed ID: 32658080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ulinastatin shows preventive effect on post-endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study.
    Fujishiro H; Adachi K; Imaoka T; Hashimoto T; Kohge N; Moriyama N; Suetsugu H; Kawashima K; Komazawa Y; Ishimura N; Ishihara S; Amano Y; Kinoshita Y
    J Gastroenterol Hepatol; 2006 Jun; 21(6):1065-9. PubMed ID: 16724996
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etanercept, a TNF-alpha binding agent, is ineffective in the prevention of post-ERCP pancreatitis in canines.
    Buscaglia JM; Simons BW; Prosser BJ; Ruben DS; Giday SA; Magno P; Clarke JO; Shin EJ; Kalloo AN; Kantsevoy SV; Gabrielson KL; Jagannath SB
    JOP; 2008 Jul; 9(4):456-67. PubMed ID: 18648137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial.
    Andrade-Dávila VF; Chávez-Tostado M; Dávalos-Cobián C; García-Correa J; Montaño-Loza A; Fuentes-Orozco C; Macías-Amezcua MD; García-Rentería J; Rendón-Félix J; Cortés-Lares JA; Ambriz-González G; Cortés-Flores AO; Alvarez-Villaseñor Adel S; González-Ojeda A
    BMC Gastroenterol; 2015 Jul; 15():85. PubMed ID: 26195123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.